Team:TU-Eindhoven/Applications

From 2013.igem.org

(Difference between revisions)
Line 26: Line 26:
-->
-->
{| style="float: left;" border="1"
{| style="float: left;" border="1"
-
| '''Application'''
+
! scope="col" | '''Application'''
-
| '''Strengths'''
+
! scope="col" | '''Strengths'''
-
| '''Weaknesses'''
+
! scope="col" | '''Weaknesses'''
|-
|-
-
| Tumor Imaging
+
! scope="col" | Tumor Imaging
-
| rowspan="2" |  
+
! scope="col" | rowspan="2" |  
*Safer and more efficient approach.
*Safer and more efficient approach.
*It is possible to localize and target a specific site based on a certain characteristic.
*It is possible to localize and target a specific site based on a certain characteristic.

Revision as of 15:12, 10 September 2013

Application Strengths Weaknesses
Tumor Imaging rowspan="2" |
  • Safer and more efficient approach.
  • It is possible to localize and target a specific site based on a certain characteristic.
  • The use of bacteria as a transporting vessel and a production device to generate the CEST MRI contrast agent in situ allows a higher carrying capability.
  • Low production cost.
  • At the moment it is not possible to reach areas with a weak hypoxic environment, this means that it is not possible to detect metastasis.
  • Societal problems derived from the use of bacteria in humans and animals might be an obstacle for the distribution and usage of the bacterial CEST MRI contrast agent.
  • There is a constant mutation risk. This risk is low but latent.
Bacterial Tracking